Alfresa Holdings Corporation (ALFRY)

Market Cap	2.85B +17.0%
Revenue (ttm)	19.53B +4.1%
Net Income	214.58M -2.2%
EPS	1.18 +0.3%
Shares Out	n/a
PE Ratio	13.27
Forward PE	n/a
Dividend	0.44 (2.72%)
Ex-Dividend Date	Mar 30, 2026

Volume	100
Average Volume	1,637
Open	16.23
Previous Close	16.39
Day's Range	16.23 - 16.23
52-Week Range	11.39 - 16.39
Beta	-0.27
RSI	n/a
Earnings Date	May 15, 2026

About Alfresa Holdings

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is also involved in the operation of dispensing pharmacies and conducting related businesses; ethical pharmaceuticals wholesaling business; self-medication products wholesaling business; and other medical-related businesses. In addition, the company manufactures and markets active pharmaceutical ingredients; contract dis...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2003
• Employees: 12,452
• Stock Exchange: OTCMKTS
• Ticker Symbol: ALFRY

Financial Performance

In fiscal year 2025, Alfresa Holdings's revenue was 2.96 trillion, an increase of 3.59% compared to the previous year's 2.86 trillion. Earnings were 27.39 billion, a decrease of -7.34%.

Financial numbers in JPY